Safer Scooters on the Streets of Rome, Heading to London Trials
LINK, the shared electric scooter service created by OurCrowd portfolio company Superpedestrian, launches...
Quality and Taste Triple Tovala Sales Ahead of Investment Round
Smart meal service delivery company outperforms competition
OurCrowd investors join Series B round led by...
Tel Aviv, Israel (August 5, 2020) – Sight Diagnostics, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today...
Sight Diagnostics has raised $71 million to help expand the commercial reach of its FDA-cleared, tabletop machine for analyzing a finger-prick’s worth of...
Koch Disruptive Technologies has announced an investment in Sight Diagnostics alongside global crowdfunding platform OurCrowd. Sight Diagnostics is a long time portfolio company of OurCrowd. The Series D...
Israel’s Sight Diagnostics said on Wednesday it raised $71 million in private funding to expand sales of its finger-prick blood analyzer and support...
Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D...
Tel Aviv, Israel-based Sight Diagnostics, which makes a complete blood count (CBC) analyzer only requiring two drops of blood, announced Wednesday that it...
OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of...